Therapeutic Respiratory Devices By Product Type (Positive Airway Pressure Devices {Continuous Positive Airway Pressure, Bilevel Positive Airway Pressure, Automatic Positive Airway Pressure}, Oxygen Concentrators {Portable Oxygen Concentrators, Stationary Oxygen Concentrators}, Ventilators {Invasive Ventilators, Non-Invasive Ventilators}, Inhalers {Metered Dose Inhalers, Dry Powder Inhalers}, Nebulizers {Ultrasonic, Jet, Mesh}, Humidifiers & Airway Clearance Devices), By Application (Chronic Obstructive Pulmonary Disease, Asthma, Sleep Apnea, Cystic Fibrosis, Respiratory Distress Syndrome, Others), By Portability (Portable Devices, Stationary Devices), By End-user (Hospitals & Clinics, Homecare Settings, Ambulatory Surgical Centers, Rehabilitation Centers, Others), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 – 2035

---

What trends will shape the Therapeutic Respiratory Devices Market in the coming years?

The Therapeutic Respiratory Devices Market accounted for USD 18.2 Billion in 2024 and USD 19.7 Billion in 2025. It is expected to reach USD 34.19 Billion by 2035, growing at a CAGR of around 5.93% between 2025 and 2035. The Therapeutic Respiratory Devices Market encompasses product categories used to treat respiratory disorders, including COPD, asthma, and sleep apnea, which comprise Auto Ventilators, Nebulizers, Oxygen Concentrators, and Inhalers.

One of the reasons attributed to the growth of the market is an increase in the frequency of chronic respiratory diseases, growing age populations, and air pollution. Among the most significant tendencies that are defining the future are the tendency to provide home-based care, the development of portable and wearable respiratory systems, and the use of AI and IoT to conduct contemporary monitoring. The market will also be intensified by the use of technology and the increasing access to healthcare facilities in the emerging economies. Personalized therapy and distributed respiratory care are also indicated in the future scope. 

What do industry experts say about the Therapeutic Respiratory Devices Market trends?

"Therapeutic respiratory devices, including CPAP and BiPAP machines, are critical in managing obstructive sleep apnea and chronic respiratory failure. These devices improve patient outcomes by maintaining airway patency and enhancing gas exchange."

• Dr. MeiLan K. Han, Chief of Pulmonary and Critical Care, University of Michigan

Which segments and geographies does the report analyze?

What are the key drivers and challenges shaping the Therapeutic Respiratory Devices Market?

How is rising COPD prevalence globally driving therapeutic device adoption?

It is projected that the Therapeutic Respiratory Devices Market will grow greatly because the prevalence of chronic obstructive pulmonary disease (COPD) occurs on a higher scale globally, and it is a great cause of mortality and morbidity. The prevalence of COPD wrought a huge health burden on the global population, with around 480 million individuals estimated to be impacted by the disease as of 2020, nearly 10.6% of the world population. Pollution of the environment, upsurge in tobacco consumption, and occupational exposure to harmful dust and chemicals have had an immense effect on this escalating trend, particularly in low- and Middle-income countries. Millions of people are affected, so an efficient strategy of management and treatment is required. That has made such gadgets as oxygen concentrators, CPAP machines, nebulizers, and non-invasive ventilators in demand.

These gadgets come in handy in terms of symptom management and enhancement of the lives of patients. Health care organizations and governments are also making more investments in respiratory care programs. Such devices have become increasingly important in the early diagnosis and long-term treatment plans. The healthcare systems are feeling the burden of hospitalization due to COPD exacerbations. The Therapeutic Respiratory Devices Market is hence going to be imperative in dealing with chronic diseases. Accessibility is also experiencing an increase due to innovations in portable and home-use devices. This increased awareness is translated into increased patient compliance, which in turn stimulates the use even more.

Can technological innovations improve treatment outcomes for respiratory disorders?

The Therapeutic Respiratory Devices market is currently redefining itself due to constant technological advancements that have had a remarkable impact on the results of respiratory treatment. The interconnection of AI and the IoT with smart sensors has made it possible to track data in real-time and forecast diagnostics, as well as to implement custom respiratory treatment. Case in point, the modern inhalers are now equipped with dose-monitoring capabilities, informing the patients and doctors when they forget to take their medication or when they err in the method of consumption. There has been an emergence of more exacting, adaptive, and user-friendly ventilators and oxygen delivery systems. These technologies minimize imperfection in accuracy, boost performance, and maximize patient outcomes.

At the same time, the increasing global burden of respiratory problems is escalating the necessity of advanced solutions. The population affected by COPD was more than twofold in 1990 (100 million) and 2021 (213 million), with deaths and disability-adjusted life years (DALYs) doubled (2.5 million and 56.9 million in 1990 and 3.72 million and 79.8 million in 2021, respectively). These troublesome figures compound the need for scalable, innovative respiratory solutions. Advancements in therapeutic devices additionally solve the medical need, but it has also provided the healthcare systems with an efficient method to treat problems such as chronic conditions cost-effectively. These solutions are deemed not only necessary, but also critical in preventing the lasting effects of respiratory illness in cases of the Therapeutic Respiratory Devices Market as it continues to make progress.

Do high device costs limit access in developing healthcare systems?

The high cost of the devices is a major challenge in the Therapeutic Respiratory Devices Market, in spite of the advanced technology used, because the affordability of the devices immensely restricts their usage in low-income and middle-income sections. Sophisticated and mobile ventilators, oxygen concentrators, and digital CPAP machines have high upfront development costs and costs of maintenance. This cost constraint restricts their mass application in the poorly funded national health care systems. The out-of-pocket spending is required in the majority of the areas, so it does not allow access to the small segment of the population.

In the individual healthcare sector as well, affordability is an issue, especially for long-term users of therapy. Services such as after-sales services as replacement of filters, routine ongoing maintenance, and technical assistance are also included in the cost of GE-Colony. Patients can choose to keep or not seek care when there are no proper subsidies or health insurance coverage. As a result, the level of market penetration in the rural or underserved areas is very low. The Therapeutic Respiratory Devices Market can hardly achieve its potential unless the issue of price sensitivity is addressed. The pressure is burdening manufacturers, especially in balancing innovative ideas with the effects on cost.

Will AI-powered monitoring enhance personalized respiratory care solutions?

The Therapeutic Respiratory Devices Market holds great potential in the power of the AI-based solution, where targeted and effective use of respiratory therapy can be delivered. The incorporation of artificial intelligence in appliances such as ventilators, inhalers, and oxygen concentrators will enable clinicians to have real-time information about the patient, including the oxygen saturation rate, breathing patterns, and medication adherence. These insights enable dynamic changes in treatment in relation to the needs of individual patients. As an example, AI-enhanced smart inhalers help alert patients or care professionals in real-time in case of misuse.

It is also possible to predict possible exacerbation of such conditions as asthma or COPD with the help of predictive analytics and provide early intervention. This not only enhances the outcome of the treatment but also patient adherence and satisfaction. Remote patient monitoring is an essential process in the care of a chronic disease and can be enabled by AI-based systems. The Therapeutic Respiratory Devices Market will be a beneficiary since the technologies will cut down the number of hospital readmissions and healthcare expenses. The cloud-based solutions allow the doctors to monitor and modify therapy regimens without visiting them. This personalization is particularly useful to pediatric and aged patients whose respiratory issues are sensitive.

Can portable devices revolutionize home-based chronic disease management?

One of the huge opportunities of the Therapeutic Respiratory Devices Market is the increased popularity of portable respiratory devices, which in turn is leading to significant home-based chronic care management. Patients with conditions such as COPD, sleep apnea, or pulmonary fibrosis may need respiratory support at all times. Devices that they can use to continue treatment at home include lightweight oxygen concentrators, portable nebulizers, and travel-weight CPAP. This transition enables patients to have more control and freedom when dealing with their condition. It also eases the pressure on the health care systems through fewer hospitalizations and inpatient expenditure.

The need for such solutions has increased significantly, including after the pandemic, when the acceptance of home care has grown. Their usage is spreading to elderly and travel-sensitive patients as these devices are increasingly becoming ergonomic and power-efficient. The Therapeutic Respiratory Devices Market is thereby shifting to a more patient-focused care model. The long-term outcomes associated with respiratory management at home are improved because of increased therapy compliance. The use of telehealth also increases the possibility of supporting and monitoring those remotely. The manufacturers of the portable devices are also venturing into slim designs and connectivity through wireless to appeal to the technology-conscious customers.

What are the key market segments in the Therapeutic Respiratory Devices industry?

Based on the Product Type, the Therapeutic Respiratory Devices Market has been classified into Positive Airway Pressure (PAP) Devices, Oxygen Concentrators, Ventilators, Inhalers, Nebulizers and Humidifiers, and Airway Clearance Devices. Positive Airway Pressure Devices are the biggest players, followed by the others, because of their superiority in the treatment of sleep apnea and other chronic respiratory diseases.

The spread of sleep-related breathing disorders and the emergence of home-care therapy have greatly contributed to the demand for the CPAP, BiPAP, and APAP machines. Moreover, their adoption is being improved by such technological advances as auto-adjusting features and the use of mobile apps. Even oxygen concentrators and ventilators are experiencing a rise, particularly due to the occurrence of respiratory pandemics and the population of the elderly.

Based on the Application, the Therapeutic Respiratory Devices Market has been classified into Chronic Obstructive Pulmonary Disease, Asthma, Sleep Apnea, Cystic Fibrosis, Respiratory Distress Syndrome, and Others. The Chronic Obstructive Pulmonary Disease (COPD) segment has the highest market share owing to the increasing cases of COPD globally, which is caused by smoking, nicotine, air pollution, or an aging population.

The need to provide long-term respiratory care among COPD patients is driving the use of different devices, especially oxygen concentrators and PAP systems. Other large contributors are asthma and sleep apnea segments because of their widespread occurrence, and due to inhalation and PAP devices that are easy to use. These segments are also aided by emerging awareness campaigns and a better rate of diagnosis. Moreover, respiratory distress syndrome and cystic fibrosis (though being niche) will trigger innovation in the neonatal and pediatric respiratory care solution category.

Which regions are leading the Therapeutic Respiratory Devices Market, and why?

The North American Therapeutic Respiratory Devices Market region occupies the highest share, basically due to the high rate of respiratory diseases, including COPD and sleep apnea, as well as the presence of an existing health facilities infrastructure. The area enjoys well-established reimbursement structures, broad knowledge, and the use of high-tech solutions in the respiratory domain.

Along with that, the existence of a large market, major players, and continued investments in R&D lead to continuous growth. The U.S. is the highest market with a thriving need for PAP devices, oxygen therapies, as well as intelligent inhalers. The growth of home care respiratory therapy is another factor that promotes the growth of the market in North America.

The Asia-Pacific Therapeutic Respiratory Devices Market is the fastest-growing market, driven by a rapidly aging population, rising pollution levels, and growing respiratory diseases related to smoking. Other nations such as China, India, and Japan are undergoing increased spending on healthcare and the production of medical technologies.

The adoption is due to government efforts to advance the healthcare infrastructure and increase access to low-cost machinery. Furthermore, the trend towards home-based care and the increasing number of people in the middle classes are increasing the demand. As understanding levels progress and the diagnostics level progresses, the Asia-Pacific will remain on its upward slope in this market.  

What does the competitive landscape of the Therapeutic Respiratory Devices Market look like?

The Therapeutic Respiratory Devices Market is moderately concentrated in terms of competition, where some of the global and regional companies remain very active in terms of innovation, mergers, collaborations, and geographical expansions. Notable firms in the industry are Philips Healthcare, ResMed Inc., Medtronic plc, GE Healthcare, Fisher and Paykel Healthcare, Dragerwerk AG, ICU Medical (Smiths Medical), DeVilbiss Healthcare, and Invacare Corporation. These companies pay much attention to R&D, creating advanced, user-friendly, and portable devices connected with AI and IoT to monitor them in real-time. Most are spending on developing their product lines to serve both hospital and homecare facilities. Their acquisitions and partnership with hospitals and digital health platforms are giving them a competitive advantage.

As an example, ResMed focuses on cloud-compatible CPAP solutions, whereas Philips constantly develops their sleep and respiratory treatment range by including smart technology. Worldwide, the players are also penetrating the emerging markets with low-cost products and local production. Furthermore, the companies are using integration of telehealth and software-based platforms to administer remote respiratory therapy, leading to better patient compliance and long-term care outcomes. On the whole, innovation and affordability, as well as patient-centric solutions, continue to play a key role in the competitive strategy in this market.

Therapeutic Respiratory Devices By Product Type (Positive Airway Pressure Devices {Continuous Positive Airway Pressure, Bilevel Positive Airway Pressure, Automatic Positive Airway Pressure}, Oxygen Concentrators {Portable Oxygen Concentrators, Stationary Oxygen Concentrators}, Ventilators {Invasive Ventilators, Non-Invasive Ventilators}, Inhalers {Metered Dose Inhalers, Dry Powder Inhalers}, Nebulizers {Ultrasonic, Jet, Mesh}, Humidifiers & Airway Clearance Devices), By Application (Chronic Obstructive Pulmonary Disease, Asthma, Sleep Apnea, Cystic Fibrosis, Respiratory Distress Syndrome, Others), By Portability (Portable Devices, Stationary Devices), By End-user (Hospitals & Clinics, Homecare Settings, Ambulatory Surgical Centers, Rehabilitation Centers, Others), Global Market, Company Shares Analysis, 2024

To explore in-depth analysis in this report - Request Sample Report

Which recent mergers, acquisitions, or product launches are shaping the Therapeutic Respiratory Devices industry?

• In June 2025, ResMed presented research at SLEEP 2025 showing that CPAP therapy reduces cardiovascular-related emergency room visits by 22%, highlighting significant patient health benefits and reinforcing the clinical importance of respiratory support in chronic conditions.
• In March 2025, ResMed unveiled a unified global branding strategy to integrate its sleep, breathing, and home care technologies, aiming to enhance patient-centric care, expand its direct-to-consumer (D2C) outreach, and streamline its global respiratory device offerings.

Report Coverage:

By Product Type

• Positive Airway Pressure Devices

Continuous Positive Airway Pressure

• Bilevel Positive Airway Pressure
• Automatic Positive Airway Pressure

• Oxygen Concentrators
  • Portable Oxygen Concentrators
  • Stationary Oxygen Concentrators
• Ventilators
  • Invasive Ventilators
  • Non-Invasive Ventilators
• Inhalers
  • Metered Dose Inhalers
  • Dry Powder Inhalers
• Nebulizers
  • Ultrasonic
  • Jet
  • Mesh
• Humidifiers & Airway Clearance Devices

By Application

• Chronic Obstructive Pulmonary Disease
• Asthma
• Sleep Apnea
• Cystic Fibrosis
• Respiratory Distress Syndrome
• Others

By Portability

• Portable Devices
• Stationary Devices

By End User

• Hospitals & Clinics
• Homecare Settings
• Ambulatory Surgical Centers
• Rehabilitation Centers
• Others

By Region

North America

• U.S.
• Canada

Europe

• U.K.
• France
• Germany
• Italy
• Spain
• Rest of Europe

Asia Pacific

• China
• Japan
• India
• Australia
• South Korea
• Singapore
• Rest of Asia Pacific

Latin America

• Brazil
• Argentina
• Mexico
• Rest of Latin America

Middle East & Africa

• GCC Countries
• South Africa
• Rest of Middle East & Africa

List of Companies:

• GE Healthcare
• Koninklijke Philips N.V.
• ResMed Inc.
• Medtronic plc
• Fisher & Paykel Healthcare Ltd
• Drägerwerk AG & Co. KGaA
• ICU Medical
• Invacare Corporation
• DeVilbiss Healthcare
• Linde plc
• Mindray Medical International
• Chart Industries
• Getinge AB
• Masimo Corporation
• Hill‑Rom Services

Frequently Asked Questions (FAQs)